Mode
Text Size
Log in / Sign up

ADOS-2 shows 0.88 sensitivity and 0.74 specificity for diagnosing autism spectrum disorderNew analysis shows how well the ADOS tool identifies autism

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that ADOS-2 provides high sensitivity (0.88) but lower specificity in higher modules for autism diagnosis.

This systematic review and meta-analysis evaluates the diagnostic accuracy of the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) compared to DSM- or ICD-based clinical best-estimate diagnoses in real-world referral populations. The analysis included 10 studies for qualitative synthesis, with 6 studies providing extractable data for quantitative pooling.

The meta-analysis reported an overall pooled sensitivity of 0.88 (95% CI: 0.83–0.92) and a pooled specificity of 0.74 (95% CI: 0.68–0.80). The overall HSROC AUC was 0.86. Notably, the Toddler Module demonstrated higher performance compared to other modules, with a sensitivity of 0.92, specificity of 0.88, and an AUC of 0.94.

A primary limitation noted is the reduced specificity in higher ADOS-2 modules (Modules 3 and 4). Clinical utility is influenced by setting; lower specificity was associated with psychiatric referral settings and adult samples. These findings suggest that while the ADOS-2 is highly sensitive, its specificity varies depending on the specific module used and the patient population.

How this fits prior evidence

This meta-analysis addresses a gap in validating diagnostic tools for autism spectrum disorder. While previous evidence explored artificial intelligence as a potential tool for diagnosis, this study provides quantitative data on the performance of the ADOS-2. It confirms that while certain interventions like tDCS and TMS biomarkers are being explored for symptom management and biomarker identification, the ADOS-2 remains a primary clinical tool with high sensitivity but variable specificity across different modules.

Getting a clear diagnosis for autism can be a long and difficult journey for families. Doctors often rely on specific tools to help make these decisions. One of the most common tools used today is called the ADOS-2. A recent review of several studies looked at how accurately this tool identifies autism in real-world clinical settings.

The analysis found that the ADOS-2 has high sensitivity, meaning it is very good at correctly identifying people with autism. It performed especially well for toddlers, showing even higher accuracy in those cases. However, the tool was less specific in some areas, which means it sometimes flagged individuals as having autism when they did not.

This happens more often in certain situations, such as when using the higher modules of the test or when evaluating adults. While the ADOS-2 is a strong tool for diagnosis, its accuracy can change depending on who is being tested and which part of the test is used. These findings help doctors understand the strengths and limits of this common screening tool.

What this means for you:
The ADOS-2 tool shows high sensitivity in identifying autism, especially in toddlers.

Common questions

How accurate is the ADOS-2 test for children?

The ADOS-2 shows very high performance for toddlers. In this study, the toddler module had a sensitivity of 0.92 and a specificity of 0.88. These numbers suggest it is quite effective at identifying autism in very young children.

Is the ADOS-2 accurate for all types of patients?

The accuracy can vary depending on the patient group. While the tool has high overall sensitivity, it showed lower specificity in higher modules and among adult samples. This means it may be less precise in those specific cases.

What does 'sensitivity' mean for this test?

Sensitivity refers to how well a test identifies people who actually have a condition. The ADOS-2 showed an overall pooled sensitivity of 0.88, meaning it is very good at correctly identifying individuals with autism.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundThe Autism Diagnostic Observation Schedule, Second Edition (ADOS-2), is widely used in the diagnostic evaluation of autism spectrum disorder (ASD); however, its diagnostic performance in real-world clinical referral populations remains heterogeneous, particularly across modules and clinical contexts. This systematic review and meta-analysis evaluated the module-specific diagnostic accuracy of ADOS-2 using hierarchical meta-analytic modeling and examined sources of heterogeneity in updated evidence clinical studies.MethodsA systematic search of PubMed/MEDLINE, Scopus, and Web of Science was conducted from January 2021 to February 2026, with additional screening of reference lists. Studies were included if they evaluated ADOS-2 diagnostic accuracy in real-world clinical referral populations, used DSM- or ICD-based clinical best-estimate diagnosis as the reference standard, and reported extractable 2×2 data. Diagnostic accuracy was pooled using a hierarchical summary receiver operating characteristic (HSROC) model with a bivariate random-effects approach. Module-specific analyses (Toddler Module, Modules 1–2, Module 3, Module 4) and meta-regression were performed to examine heterogeneity.ResultsTen studies were included in the qualitative synthesis, and six provided extractable 2×2 data for quantitative pooling. Overall pooled sensitivity was 0.88 (95% CI: 0.83–0.92) and pooled specificity was 0.74 (95% CI: 0.68–0.80), with an HSROC AUC of 0.86. The Toddler Module showed the highest diagnostic performance (sensitivity 0.92; specificity 0.88; AUC 0.94), whereas specificity decreased in Modules 3 and 4. Meta-regression identified module level, psychiatric referral setting, and adult samples as significant contributors to reduced specificity. No significant publication bias was detected.ConclusionsADOS-2 demonstrates high overall sensitivity but variable specificity across modules in real-world clinical referral populations. Reduced specificity was more commonly observed in higher ADOS-2 modules, which are typically administered to verbally fluent adolescents and adults with greater psychiatric complexity.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.